Tag Archive for: analysts

Sector updates in November

Investment firms Sofinnova Partners successfully closes its latest flagship fund, Sofinnova Capital XI, with €650 million to back a new generation of pioneering biopharmaceutical and medical technology companies addressing urgent unmet clinical needs Medicxi successfully closes its sixth fund, Medicxi V, with €500 million dedicated to building and backing innovative biotechnology companies with clear product […]

Resolution Therapeutics to Host Virtual Webinar on Liver Disease with World Leading Hepatologist Arun Sanyal, M.D.

Highlighting Clinical Data and Discovery Platform Following Presentations at EASL Congress 2024 Edinburgh and London, UK, 13 June 2024 – Resolution Therapeutics Limited (“Resolution”), a clinical-stage biopharmaceutical company developing macrophage cell therapies to treat end-stage liver disease, today announces that it will host a virtual R&D webinar on Friday 28th June 2024 at 12.30 BST / 7.30 […]